Roche Investor Relations Manager Salaries in San Francisco | Comparably
Roche Claimed Company
The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. read more
EMPLOYEE
PARTICIPANTS
674
TOTAL
RATINGS
4509
HR or Marketing? Claim Your Free Employer Account

Roche Investor Relations Manager Salaries in San Francisco

The average Roche Investor Relations Manager in San Francisco earns an estimated $96,840 annually. Roche's Investor Relations Manager compensation is $9,537 more than the US average for a Investor Relations Manager.

In San Francisco, The Communications Department at Roche earns $13,435 more on average than the Enterprise Risk Department.

Last updated 22 days ago.

$51k
$64k
$75k
$85k
$114k
$175k
$96,840
Average Compensation
$96,840
avg. base

Investor Relations Manager Salaries at Roche

* estimated salary

Compensation at Roche by Department

In San Francisco, The Communications Department averages $13,435 more than the Enterprise Risk Department.

Communications
$194,994 Avg. total comp.
Enterprise Risk
$181,559 Avg. total comp.
-$13k
Product
$147,148 Avg. total comp.
-$48k

Investor Relations Manager Compensation by Gender (All Companies)

The average female Investor Relations Manager at companies similar size to Roche reported making $152,500, while the average male Investor Relations Manager at similar sized companies reported making $75,500.

Investor Relations Manager Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Investor Relations Manager at companies similar size to Roche reported making $175,000, while the average Caucasian Investor Relations Manager at similar sized companies reported making $70,250.

How Investor Relations Managers at Roche Rate Their Compensation

The majority of Investor Relations Managers at Roche believe they're compensated fairly. 100% of Investor Relations Managers at Roche say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Roche

×
Rate your company